1Merlini G, Bellotti V. Molecular Mechanisms of Amyloidosis [ J ].N Engl J Med,2003,349(6):583-596. 被引量:1
2Sirohi B, Powles R. Epidemiology and Outcomes Research for MGUS,Myeloma and Amyloidosis [ J ].Eur J Cancer,2006, 42(11):1671-1683. 被引量:1
3Gertz M A, Comenzo R, Falk R H, et al. Definition of Organ Involvement and Treatment Response in Immunoglobulin Light Chain Amyloidosis(AL): a Consensus Opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004[ J ]. Am J Hematol, 2005, 79(4):319-328. 被引量:1
5C.ertz MA,Comenzo R,Falk RH,et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis(AL): a consensus opinion from the lOth international symposium on umyloid and amyloidosis, Tours, France, 18-22 April 2004 [J]. Am J Hematol, 2005,79 : 319-328. 被引量:1
6Sook-BW,Stephen T,Michael M,et al. A longitudinal study of oral ural ulcerative mucositis in bone marrow transplant recipients[J].Caneer,1993,72(5):1612-1617. 被引量:1
7Falk BH. Diagnosis and management of the cardiac amyloidoses [J]. Circulation, 2005,112: 2047-2060. 被引量:1
8Gertz MA, Merlini G, Treon SP. Amyloidosis and Waldenstrom's macroglobulinemia[J]. Hematology Am Soc Hematol Educ Program,2004, 257-282. 被引量:1
9Jantunen Early treatment-related morality in aduk autologous stera ceil transplant recipients:a nation-wide survey of 1482 transplanted Patients[J]. Eur J Haematol,2006,76:245-250. 被引量:1